The UK’s Cannabis Industry Council (CIC) has launched a new report calling for industrial hemp regulation to be transferred from the Home Office to the Department for Environment, Food and Rural Affairs (DEFRA), arguing that the current licensing regime is holding back a crop capable of helping the UK meet its binding Net Zero commitments.
The Advisory Council on the Misuse of Drugs (ACMD) has closed its latest call for evidence into the impact of medical cannabis legalisation, in what will mark the most comprehensive review of the UK’s cannabis-based products for medicinal use (CBPM) framework since it was introduced in 2018.
New data acquired from the Home Office by Prohibition Partners and Business of Cannabis shows that since 2021, the UK has imported the bulk of its medical cannabis from Spain.
Responsibility for all medical cannabis policy and regulation should sit with the Department of Health and Social Care (DHSC), according to the Cannabis Industry Council (CIC).
Last week, the UK Home Office announced some significant changes to its licensing framework for the country’s industrial hemp industry.
